Diabetic myopathy: MRI patterns and current trends.

AJR Am J Roentgenol

Department of Imaging Sciences, University of Rochester Medical Center, NY 14642, USA.

Published: July 2010

AI Article Synopsis

  • The study investigates diabetic myopathy in a hospital population, focusing on MRI findings and muscle involvement patterns.
  • The retrospective analysis included MRI reports and clinical data from patients diagnosed with diabetic myopathy over a 79-month period, revealing significant coexisting complications like nephropathy and neuropathy.
  • The results indicate that diabetic myopathy is more common in type 2 diabetes patients, emphasizing the importance of MRI for diagnosis while cautioning against the use of gadolinium-based contrast due to risks associated with kidney complications.

Article Abstract

Objective: This study retrospectively evaluates diabetic myopathy in a large referral hospital population. It describes the MRI findings and the distribution of muscle involvement, including comparison with clinical parameters.

Materials And Methods: MRI reports of the lower extremities from July 1999 through January 2006 were reviewed and compared with clinical parameters for patients with diabetic myopathy. Clinical parameters (e.g., type of diabetes, hemoglobin A(1C) level, creatine kinase level, and erythrocyte sedimentation rate [ESR]) and the presence of complications, including nephropathy, neuropathy, and retinopathy, were noted. The distribution of muscle involvement and imaging features were reviewed.

Results: Over a 79-month period, 21 extremities (11 thighs and 10 calves) of 16 patients were imaged. Fourteen (88%) patients had type 2 diabetes, and two (12%) had type 1 diabetes. Four patients (25%) had disease in more than one location. In the thigh, the anterior compartment was involved in all patients. The posterior compartment was affected in nine (90%) of 10 calves. Muscle infarction and necrosis was seen in eight (38%) extremities. The creatine kinase level, ESR, and hemoglobin A(1C) level were elevated in the majority of cases. Coexisting nephropathy (50%), neuropathy (50%), and retinopathy (38%) were present in these patients.

Conclusion: Diabetic myopathy may occur more frequently in patients with type 2 diabetes than previously reported. In this population, T2-weighted and contrast-enhanced images have similar findings, and the increased coexistence of nephropathy makes administration of gadolinium-based contrast agents ill-advised. With a typical clinical presentation and MRI findings, a confident diagnosis can be made, and potentially harmful biopsy is avoided. Diabetic myopathy encompasses a spectrum of diseases, including muscle inflammation, ischemia, hemorrhage, infarction, necrosis, fibrosis, and fatty atrophy. It is usually seen with long-standing, poorly controlled diabetes.

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.09.2494DOI Listing

Publication Analysis

Top Keywords

diabetic myopathy
20
type diabetes
16
mri findings
8
distribution muscle
8
muscle involvement
8
clinical parameters
8
hemoglobin a1c
8
a1c level
8
creatine kinase
8
kinase level
8

Similar Publications

Coenzyme Q10 (CoQ10) plays a crucial role in facilitating electron transport during oxidative phosphorylation, thus contributing to cellular energy production. Statin treatment causes a decrease in CoQ10 levels in muscle tissue as well as in serum, which may contribute to the musculoskeletal side effects. Therefore, we aimed to assess the effect of newly initiated statin treatment on serum CoQ10 levels after acute ST-elevation myocardial infarction (STEMI) and the correlation of CoQ10 levels with key biomarkers of subclinical or clinically overt myopathy.

View Article and Find Full Text PDF

The objective of this study was to explore if the time of day (AM vs PM) resistance exercise is performed influences glucose and insulin concentrations, body composition, and muscular strength in adults with prediabetes. A secondary data analysis was conducted using data from the "Resist Diabetes" study, a phase II exercise intervention. Participants (Age:59.

View Article and Find Full Text PDF

Diagnosis and Management of Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes Syndrome.

Biomolecules

November 2024

Departments of Pediatrics, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06229, Republic of Korea.

Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a complex mitochondrial disorder characterized by a wide range of systemic manifestations. Key clinical features include recurrent stroke-like episodes, seizures, lactic acidosis, muscle weakness, exercise intolerance, sensorineural hearing loss, diabetes, and progressive neurological decline. MELAS is most commonly associated with mutations in mitochondrial DNA, particularly the m.

View Article and Find Full Text PDF

Striking Cardioprotective Effects of an Adiponectin Receptor Agonist in an Aged Mouse Model of Duchenne Muscular Dystrophy.

Antioxidants (Basel)

December 2024

Pole of Cardiovascular Research, Institute of Experimental and Clinical Research (IREC), Université Catholique de Louvain (UCLouvain), Avenue Hippocrate 55, 1200 Brussels, Belgium.

Adiponectin (ApN) is a hormone with potent effects on various tissues. We previously demonstrated its ability to counteract Duchenne muscular dystrophy (DMD), a severe muscle disorder. However, its therapeutic use is limited.

View Article and Find Full Text PDF

Macrophage Immunometabolism - Emerging Targets for Regrowth in Aging Muscle.

Am J Physiol Endocrinol Metab

January 2025

Diabetes & Metabolism Research Center, University of Utah, Salt Lake City, UT, 84112.

The recovery from muscle atrophy is impaired with aging as characterized by improper muscle remodeling and sustained functional deficits. Age-related deficits in muscle regrowth are tightly linked with the loss of early pro-inflammatory macrophage responses and subsequent cellular dysregulation within the skeletal muscle niche. Macrophage inflammatory phenotype is regulated at the metabolic level, highlighting immunometabolism as an emerging strategy to enhance macrophage responses and restore functional muscle regrowth.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!